Paper211167
Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
Levy NL. J Immunol, 1978. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. Papers, record 211167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/211167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Immunity, Cellular | Major topic |
| Astrocytoma | |
| Cross Reactions | |
| Ependymoma | |
| Glioblastoma | |
| Glioma | |
| Humans | |
| Immunosorbent Techniques | |
| Lymphocytes | |
| Meningioma |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7180599 | Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/7180599 | PubMed |
| 6999846 | Tumoural antigens on experimental and human glioblastoma. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/6999846 | PubMed |
| 6986786 | Immunobiologic aspects of the brain and human gliomas. A review. | Am J Pathol | 1980 | https://conductscience.org/library/papers/6986786 | PubMed |
| 6837274 | Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells. | Acta Neuropathol | 1983 | https://conductscience.org/library/papers/6837274 | PubMed |
| 6283028 | Histocompatibility antigens on astrocytoma cells. | J Neurol Neurosurg Psychiatry | 1982 | https://conductscience.org/library/papers/6283028 | PubMed |
| 6215833 | Mechanisms by which human gliomas may escape cellular immune attack. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/6215833 | PubMed |
| 3497030 | T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. | EMBO J | 1987 | https://conductscience.org/library/papers/3497030 | PubMed |
| 3494820 | Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor. | J Neurooncol | 1987 | https://conductscience.org/library/papers/3494820 | PubMed |
| 3489081 | Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2. | J Neurooncol | 1986 | https://conductscience.org/library/papers/3489081 | PubMed |
| 3258871 | Immunocytochemical study of the cellular immune response in meningiomas. | J Clin Pathol | 1988 | https://conductscience.org/library/papers/3258871 | PubMed |
| 2702675 | Treatment of glioma with intratumoral instillation of autologous lymphocytes. | Childs Nerv Syst | 1989 | https://conductscience.org/library/papers/2702675 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/211167
GET https://conductscience.org/api/papers/v1/211167/authors